Metabolic
Amycretin
per administration
It has been used in people, but no trial has settled how much or how often.
Work out your draw
These numbers are a starting point — change any of them.
- Concentration
- 3.33mg/mL
- Volume per draw
- 1.5mL
- Units to dial
- 150
- Doses per cartridge
- 2
This is 150 units, past the 60-unit dial. Splitting it across administrations, or using less water to raise the concentration, brings it back into range.
Dial range varies by pen; 1–60 units is the common configuration.
Vial label
Copy this into your label printer.
Published research contexts for Amycretin describe 5–20 mg per administration. Descriptive only, not a recommendation.
Multi-day for the subcutaneous form; human figures are early-phase and not well characterized.
A unimolecular amylin and GLP-1 receptor co-agonist studied for weight reduction in phase 1/2 research. No confirmed dose-ranging publication fixes a subcutaneous schedule, so no schedule table is shown.
Modelled level — once a week
1× is the peak after a single dose.
- Steady-state peak
- 1.57× single dose
- Time to steady state
- 25.0days
- Administrations
- 1/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Amycretin early-phase program (Novo Nordisk)Amylin/GLP-1 co-agonist in early-phase weight research; subcutaneous amounts are not schedule-establishing.